Pi Industries Latest News: PI Industries Touches 52-Week Low of Rs 2,568.20: Key Reasons and Recovery Outlook
- June 29, 2026
- Posted by: Ankit Jaiswal
- Category: News
PI Industries latest news: NSE: PIIND Rs 2,568.20 (latest). 52W low Rs 2,568.20. 52W high Rs 4,330. MCap Rs ~40,000 Cr. P/E 30.84x. Decline from 52W high: -40.7%.
Pi Industries Latest News is a key watch for investors as PI Industries Ltd (NSE: PIIND) has touched a 52-week low of Rs 2,568.20, declining -40.7% from its 52-week high of Rs 4,330. The Agrochemicals and Contract Research Manufacturing company is facing fundamental, sectoral, and macro headwinds that have brought the stock to historically depressed levels in this PI Industries latest news story.
This PI Industries latest news analysis covers the key reasons behind the 52-week low, what analysts are observing, critical support and recovery levels, and the key risks and potential positives at current price levels.
Click Here – Get Free Investment Predictions
About PI Industries: Company Overview
A leading Indian agriscience company incorporated in 1946, headquartered in Gurugram. PI Industries operates across two segments: domestic agrochemicals distribution (over 10,000 distributors, 1.5 lakh retailers) and custom synthesis and manufacturing (CSM) for global innovators including Kumiai Chemical (Japan), Sumitomo, and Syngenta. The company has three manufacturing facilities in Gujarat, an R&D centre in Udaipur, and is expanding into pharmaceutical contract manufacturing and biologicals.
| Metric | Value |
|---|---|
| CMP (Latest) | Rs 2,568.20 |
| 52-Week High | Rs 4,330 |
| 52-Week Low | Rs 2,568.20 |
| Decline from 52W High | -40.7% |
| Market Cap | Rs ~40,000 Cr |
| P/E Ratio (TTM) | 30.84x |
| Sector | Agrochemicals and Contract Research Manufacturing |
| NSE Symbol | NSE: PIIND |
Why Is Pi Industries Latest News at 52-Week Low? Key Reasons
Three key developments have driven the PI Industries latest news stock to its current 52-week low.
FY26 Revenue Declined 16% YoY and PAT Down 20% on Global Agrochemical Downturn
PI Industries’ FY26 revenue declined approximately 16% to Rs 6,714 crore, and consolidated net profit fell 20% to Rs 1,320.8 crore. Q4 FY26 was particularly weak: EBITDA contracted 26% year-on-year to Rs 337.3 crore (margin down 402 basis points to 22%), and profit before tax fell 30% to Rs 300.5 crore. Agchem exports declined nearly 15% in Q4 FY26 due to global agrochemical industry inventory destocking, and domestic revenue softened 9% year-on-year. The PI Industries latest news of sustained earnings pressure has been the primary driver of the multi-quarter stock price decline.
Kumiai Chemical (Key Client) Cut FY26 Revenue Guidance by 5%
Kumiai Chemical Industry Co. Ltd, PI Industries’ largest overseas client and a key partner in its CSM business, cut its FY26 revenue guidance by approximately 5%, directly impacting PI Industries’ export volumes and revenue outlook. Separately, Kumiai raised its H1 2026 revenue forecast later, which provided temporary relief, but the FY26 overall decline reflects the structural global agrochemical inventory overhang that has depressed demand for Indian CSM companies. The PI Industries latest news of a 52-week low reflects the market pricing in a prolonged recovery timeline.
Global Agrochemical Inventory Destocking Cycle Extends Earnings Pressure Into FY27
The global agrochemical sector faced a severe inventory destocking cycle in FY25 and FY26 as distributors worked through excess stock accumulated during the COVID-era supply chain disruptions. Chinese generics manufacturers flooding global markets with low-cost generics added further pricing pressure on CSM companies like PI Industries. Despite 23% growth in the pharma CSM segment (now 8% of exports), the agrochemical segment headwinds have dominated the FY26 narrative. A recovery in the CSM business is expected in FY27 as global inventory normalises and new molecules ramp up production.
Use the Univest Screener to Track Live Price and Key Data
What Market Analysts Are Saying About Pi Industries Latest News
24 analysts covering PI Industries maintain an average rating of Hold with a 12-month consensus target of Rs 3,223, representing approximately 25% upside from the current 52-week low. Goldman Sachs and Morgan Stanley have noted valuation attractiveness at current levels. ICICI Prudential Mutual Fund boosted its stake to 7.16% by acquiring 4.38 lakh shares, signalling institutional confidence in the recovery potential. At 30.84x P/E and 3.57x P/B, PI Industries is trading at its lowest historical multiple in three years, though 24 analysts maintain that earnings recovery in FY27 is the key re-rating catalyst.
Ankit Jaiswal, Senior Research Analyst at Univest, notes that the PI Industries latest news fall to 52-week lows has improved the risk-reward for medium-term investors, but cautions that near-term fundamental stabilisation is needed before a sustained recovery can be confirmed. He recommends monitoring the next quarterly results as the primary signal before initiating fresh positions in PI Industries.
Kunal Singla, Research Analyst at Univest, observes that PI Industries latest news is deeply oversold on multiple technical timeframes, with Rs 2,400 as the critical weekly close support. A sustained break below this level would signal a further downtrend, while a recovery and hold above Rs 2,400 would represent the first positive signal for investors considering accumulation.
Pi Industries Latest News: Support Zones and Recovery Levels
The following price levels are being monitored in the PI Industries latest news story.
| Level | Price (Rs) | Significance |
|---|---|---|
| 52-Week Low (Current) | 2,568.20 | Multi-month low today |
| Critical Support | 2,400 | Weekly close support; break below = further downside |
| Near-Term Recovery Target | 2,900 to 3,223 | Based on analyst consensus and technical bounce zone |
| 52-Week High | 4,330 | Full recovery reference level |
These are technical reference levels and not guaranteed targets. Please consult a SEBI-registered financial advisor before making any investment decision in PI Industries.
Key Risks to Monitor
Global Agrochemical Recovery Timeline Remains Uncertain
The global agrochemical destocking cycle has lasted longer than most analysts initially projected, and any delay in FY27 recovery would create further earnings disappointment. PI Industries’ revenue visibility depends on Kumiai Chemical and other innovator clients restoring order volumes to pre-downturn levels, which is subject to global weather patterns, farm income, and regulatory timelines for new molecules.
Competitive Threat from Chinese Generic Manufacturers
Chinese agrochemical manufacturers have used the downturn to aggressively capture market share in the global generics segment, lowering prices and creating structural pricing pressure on Indian CSM companies. PI Industries competes for custom synthesis contracts in an environment where large Chinese companies offer similar capabilities at lower costs, which constrains margin expansion even when volumes recover.
Domestic Revenue Decline Reflects Rural Demand Weakness
PI Industries’ domestic agrochemical revenue declined 9% year-on-year in Q4 FY26, reflecting farmer income pressure and uneven monsoon distribution that reduced crop protection spending. If the rural agrochemical demand cycle does not recover in Q1 FY27 (the kharif season), the domestic segment will remain a headwind alongside the already-challenged export CSM business.
Conclusion
The PI Industries latest news 52-week low today reflects fy26 revenue declined 16% yoy and pat down 20% on global agrochemical downturn. Ankit Jaiswal of Univest notes the risk-reward has improved at these levels but fundamental confirmation through quarterly results is needed. Kunal Singla highlights Rs 2,400 as the critical weekly close support. Investors should track the Nifty 50 index for sector-level signals and monitor the next quarterly earnings as the primary fundamental catalyst for the PI Industries latest news story. Please consult a SEBI-registered investment advisor before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track PI Industries live price and receive expert daily stock research.
Frequently Asked Questions on Pi Industries Latest News
What is PI Industries latest news today?
Ans. PI Industries latest news is that the stock hit a 52-week low of Rs 2,568.20, falling Rs 116.70 (4.35%). The decline is driven by FY26 revenue falling 16% and PAT falling 20%, Q4 FY26 EBITDA down 26% year-on-year, Kumiai Chemical (key client) cutting its guidance, and continued global agrochemical inventory destocking. The analyst consensus target is Rs 3,223, with ICICI Prudential recently boosting its stake.
Why is PI Industries share price at 52-week low?
Ans. PI Industries is at a 52-week low because FY26 revenue declined approximately 16% and PAT declined 20% due to the global agrochemical inventory destocking cycle, Kumiai Chemical cutting its guidance by 5%, and domestic revenue declining 9% year-on-year in Q4 FY26. The stock has fallen 40.7% from its 52-week high of Rs 4,330.
What is the analyst target for PI Industries?
Ans. 24 analysts cover PI Industries with an average rating of Hold and a 12-month consensus target of Rs 3,223, representing approximately 25% upside from the 52-week low. Goldman Sachs and Morgan Stanley have noted valuation attractiveness at current levels. The recovery thesis depends on FY27 agrochemical volume normalisation and new molecule ramp-ups in the CSM business.
What is PI Industries’ FY26 performance?
Ans. PI Industries’ FY26 consolidated revenue declined approximately 16% to Rs 6,714 crore and net profit declined 20% to Rs 1,320.8 crore. Q4 FY26 was particularly weak with EBITDA down 26% and PAT down 30%. The pharma CSM segment (now 8% of exports) grew 23%, partially offsetting the 15% agchem export decline. The board recommended a Rs 10 per share final dividend for FY26.
What is PI Industries’s valuation at the 52-week low?
Ans. At the 52-week low of Rs 2,568.20, PI Industries has a market capitalisation of approximately Rs ~40,000 crore and trades at a P/E ratio of 30.84x. The 52-week high was Rs 4,330, representing a -40.7% decline to the current level. Verify all data at nseindia.com before investing.
Is PI Industries a buy at the 52-week low?
Ans. Whether PI Industries is a buy at the 52-week low depends on your investment horizon and risk tolerance. The significant decline from 52-week highs has improved the valuation, but near-term fundamental headwinds remain. Ankit Jaiswal of Univest recommends waiting for quarterly results to confirm fundamental stabilisation before initiating positions. This is not investment advice. Consult a SEBI-registered financial advisor.
